Novel agents in development for peripheral T-cell lymphoma.
about
Oral fludarabine in combination with doxorubicin and dexamethasone as first-line therapy for nodal peripheral T-cell lymphomas: early results of a prospective multicenter study.Novel therapeutics for aggressive non-Hodgkin's lymphoma.Noninvasive phosphorus magnetic resonance spectroscopic imaging predicts outcome to first-line chemotherapy in newly diagnosed patients with diffuse large B-cell lymphoma.Targeted molecular therapy in peripheral T-cell lymphomas.Update: peripheral T-cell lymphomas.Gemcitabine, oxaliplatin and dexamethasone as salvage treatment for elderly patients with refractory and relapsed peripheral T-cell lymphoma.
P2860
Novel agents in development for peripheral T-cell lymphoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Novel agents in development for peripheral T-cell lymphoma.
@en
Novel agents in development for peripheral T-cell lymphoma.
@nl
type
label
Novel agents in development for peripheral T-cell lymphoma.
@en
Novel agents in development for peripheral T-cell lymphoma.
@nl
prefLabel
Novel agents in development for peripheral T-cell lymphoma.
@en
Novel agents in development for peripheral T-cell lymphoma.
@nl
P1476
Novel agents in development for peripheral T-cell lymphoma.
@en
P2093
Owen A O'Connor
P356
10.1053/J.SEMINHEMATOL.2010.01.014
P478
47 Suppl 1
P577
2010-04-01T00:00:00Z